Questions Remain on Immunotherapy Use in Lung Cancer – Curetoday.com
Curetoday.com |
Questions Remain on Immunotherapy Use in Lung Cancer
Curetoday.com In an interview with CURE, Gandara, director of the Thoracic Oncology Program, professor at UC Davis Comprehensive Cancer Center, and a 2017 Giant of Cancer Care in Lung Cancer, discussed the latest immunotherapy developments in lung cancer and … |
